Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.
Kaowinn S, Jun SW, Kim CS, Shin DM, Hwang YH, Kim K, Shin B, Kaewpiboon C, Jeong HH, Koh SS, Krämer OH, Johnston RN, Chung YH.
Kaowinn S, et al. Among authors: kim cs, kim k.
Cell Oncol (Dordr). 2017 Dec;40(6):549-561. doi: 10.1007/s13402-017-0343-7. Epub 2017 Aug 3.
Cell Oncol (Dordr). 2017.
PMID: 28776259